Nanobiotechnology Research Group, School of Biosciences, University of Kent, Giles Lane, Canterbury, Kent, CT2 7NJ, United Kingdom.
Langmuir. 2011 Nov 15;27(22):13888-96. doi: 10.1021/la203273p. Epub 2011 Oct 24.
A detailed study into the optimization of carbodiimide-mediated coupling of antibodies (Ab) and quantum dots (QD) for use in cellular imaging has been undertaken. This involved the grafting of commercially available carboxyl-modified QDs (Evident Technologies "Lake Placid Blue" Evitag and eBioscience's eflour nanocrystals) with anti-Cdc8 Abs to produce conjugates with specific affinity for fission yeast tropomyosin Cdc8 protein. The water-soluble carbodiimide 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC) was used to activate the QDs prior to their incubation with antibody, and a range of QD-carboxyl/EDC/Ab mole ratios were used in the experiments in attempts to optimize fluorescence and bioaffinity of the conjugate products (EDC to QD-carboxyl-600 nmol/15 pmol to 0.12 nmol/15 pmol and QD to Ab 120 pmol/24 pmol to 120 pmol/1.2 pmol). It was observed that a specific "optimum" ratio of the three reactants was required to produce the most fluorescent and biologically active product and that it was generated at alkaline pH 10.8. Increasing the ratio of Ab to QD produced conjugate which was less fluorescent while reducing the ratio of EDC to QD in the activation step led to increased fluorescence of product. Conjugates were tested for their possession of antibody by measurement of their absorption at OD(280 nm) and for their fluorescence by assay λ(max(em)) at 495 nm. A quantitative assay of the bioactivity of the conjugates was developed whereby a standardized amount of Cdc8 antigen was spotted onto nylon membranes and reacted with products from conjugation reactions in a sandwich-type colormetric assay The "best" conjugate was used in intracellular imaging of yeast Cdc8 protein and produced brighter, higher definition images of fixed yeast cell actin structure than a fluorescein-Ab conjugate routinely produced in our laboratory. The QD-Ab conjugate was also significantly more resistant to photobleaching than the fluorescein-Ab conjugate. Results from other experiments involving EDC, the water-soluble carbodiimide 1-cyclohexyl-3-(2-morpholinoethyl)carbodiimide metho-p-toluenesulphonate (CMC), and EDC.HCl have suggested a new reaction mechanism for EDC coupling under basic aqueous conditions. In summary, a robust understanding of commercial QD-COOH surface chemistry and the variables involved in the materials' efficient conjugation with a bioligand using carbidiimide has been obtained along with an optimized approach for Ab-QD conjugate production. A novel assay has been developed for bioassay of QD-Ab conjugates and a new mechanism for EDC coupling under basic aqueous conditions is proposed.
已对碳化二亚胺介导的抗体(Ab)和量子点(QD)偶联的优化进行了详细研究,用于细胞成像。这涉及到用商业上可获得的羧基修饰的 QD(Evident Technologies“Lake Placid Blue”Evitag 和 eBioscience 的 eflour 纳米晶体)与抗 Cdc8 Ab 嫁接,以产生与裂殖酵母肌球蛋白 Cdc8 蛋白具有特异性亲和力的缀合物。水溶性碳二亚胺 1-乙基-3-(3-二甲基氨基丙基)碳二亚胺(EDC)用于在与抗体孵育之前激活 QD,并在实验中使用了一系列 QD-羧基/EDC/Ab 摩尔比,试图优化缀合物产物的荧光和生物亲和力(EDC 与 QD-羧基-600nmol/15pmol 至 0.12nmol/15pmol 和 QD 与 Ab 120pmol/24pmol 至 120pmol/1.2pmol)。观察到,需要三种反应物的特定“最佳”比例才能产生最荧光和最具生物活性的产物,并且在碱性 pH10.8 下生成。增加 Ab 与 QD 的比例会产生荧光较弱的缀合物,而在激活步骤中减少 EDC 与 QD 的比例会导致产物的荧光增加。通过测量 OD(280nm)处的吸收和在 495nm 处的荧光,测试了缀合物的抗体特性。开发了一种定量测定缀合物生物活性的方法,即将标准量的 Cdc8 抗原点样到尼龙膜上,并在比色夹心测定中与来自缀合反应的产物反应。“最佳”缀合物用于酵母 Cdc8 蛋白的细胞内成像,产生了比我们实验室常规产生的荧光素-Ab 缀合物更亮、更高清晰度的固定酵母细胞肌动蛋白结构图像。QD-Ab 缀合物也比荧光素-Ab 缀合物更能抵抗光漂白。涉及 EDC、水溶性碳二亚胺 1-环己基-3-(2-吗啉代乙基)碳二亚胺甲氧基对甲苯磺酸盐(CMC)和 EDC.HCl 的其他实验结果表明,在碱性水条件下,EDC 偶联存在新的反应机制。总之,已经获得了对商业 QD-COOH 表面化学和在碳化二亚胺的作用下使生物配体与材料有效偶联所涉及的变量的深入了解,同时还优化了 Ab-QD 缀合物的生产方法。已经开发了一种用于 QD-Ab 缀合物的生物测定的新测定方法,并提出了碱性水条件下 EDC 偶联的新机制。